Lifespin Gmbh Secures €2.5M Bridge Financing To Further Build Its Ai-Enabled Metabolomics-Based Differential Diagnosis Panel For Neurological Diseases

Lifespin GmbH, a deep data company currently developing a proprietary AI-based health testing platform to measure quantitative metabolic data in patient samples, has secured €2.5M bridge financing to fuel the company’s continued product development.